BHVN Q3 2024 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$178M

Net Income

-$160M

EPS (Diluted)

$-1.70

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$141M

Free Cash Flow

-$142M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$511M

Total Liabilities

$195M

Stockholders' Equity

$316M

Cash & Equivalents

$84M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$178M	-$111M	-61.2%
Net Income	-$160M	-$103M	-56.3%